3Vercaigne LM,Sitar DS,Penner SB,et al.Antibiotic-heparin lock:in vitro antibiotic stability combined with heparin in a central venous catheter[J].Pharmacotherapy,2000,20(4):394-399.
3Kim KE.Ham JY.Evaluation of the clinical performance of an automated proealcitonin assay for the quantitative detection of blood-stream infection[J].Korean J Lab Med,2010,30(2): 153-159.
4Mermel L A, AIIon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter related infection:2009 update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2009,49:1-45.
5atoli S, Fontana C, Favaro M, et al. Characterization of coagu-lase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options[J]. BMC Infect Dis, 2009, 9:78-83.
6Patil H V, Patil V C, Ramteerthkar M N, et al. Central venous catheter-related bloodstream infections in the intensive care unit [J]. Indian JCritCareMed,2011,15(4):213-223.
7Mimoz O, Villeminey S, Ragot S, et al. Chlorhexidine-based anti- septic solution vs alcohol -based povidone-iodine for central ve- nous catheter care[J]. Arch Intern Med,2007,167:2066-2072.
8Vercaigne L M, Sitar D S, Penner S B, et al. Antibiotic heparin lock: invitro antibiotic stability combined with heparin in a central venous catheter[J]. The Joumal of Human Pharmacology and Drug Thera- py, 2000, 20(4):394-399.
